Literature DB >> 22464306

Acute stroke: postprocedural care and management of complications.

Flávio Augusto de Carvalho1, Marcelo Marinho de Figueiredo, Gisele Sampaio Silva.   

Abstract

Endovascular treatment for acute ischemic stroke is an important alternative to thrombolysis with recombinant tissue plasminogen activator (rt-PA) for patients who present beyond the thrombolysis time window, those who are ineligible for rt-PA, or those who do not improve after intravenous rt-PA. These patients generally require special attention in the postprocedural period because, although not frequent, complications of endovascular procedures in acute ischemic stroke have the potential to be devastating. Neurocritical care is essential to reduce and appropriately treat complications after endovascular procedures. Neurointensivists and neurocritical care nurses are experts in both critical care and neurologic disorders and have special training to recognize early physiological derangements in patients presenting with acute stroke. Close attention to the serial neurological examination, blood pressure control, adequate management of glucose, temperature, and immediate identification of complications such as reocclusion and hemorrhagic transformation are key elements that exemplify the importance of postprocedural neurocritical care in acute ischemic stroke.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22464306     DOI: 10.1053/j.tvir.2011.12.005

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  2 in total

1.  The neuro-critical care management of the endovascular stroke patient.

Authors:  Vishal N Patel; Rishi Gupta; Christopher M Horn; Tommy T Thomas; Raul G Nogueira
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

2.  Angiographic warning of hemorrhagic transformation after stent retriever thrombectomy procedure.

Authors:  Andrew T Vollman; Charles A Bruno; Shifali Dumeer; Hani Malone; Philip M Meyers
Journal:  BMJ Case Rep       Date:  2013-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.